A B S T R AC T The kinetics of blood neutrophils was investigated by means of the in vitro radioactive diisopropyl fluorophosphate method in 35 patients with a chronic, steady-state neutropenia. There were 17 patients in whom the half disappearance time of neutrophils was normal. In 10 of these patients, the production of neutrophils was low and in 7, production was normal. In 18 patients the half disappearance time of neutrophilic granulocytes was shorter than normal. The production of neutrophilic granulocytes was low in five of these patients, normal in eight patients, and increased in five. An attempt was made to correlate other laboratory measurements with the kinetic picture, but no relationship was found; the marrow neutrophil reserve as measured by endotoxin or cortisol injection; marrow cellularity on aspiration or biopsy; in vitro-labeling index with 'HTdR; or serum lysozyme concentration proved of no value in identifying the various kinetic groups. The only finding that seemed to correlate with the kinetic picture was the presence or absence of splenomegaly. In 12 of the 18 patients with a short half disappearance time, splenomegaly was present whereas in 15 of 17 patients with a normal half disappearance time, there was no splenomegaly. Of 20 patients with greater than 1000 neutrophils per mm', 17 were found to have a normal total-blood neutrophil pool. Thus these patients, with many of their cells marginated, agree to have a "shift neutropenia."
Myelocyte to blood transit time and my-elocyte generation time, as measured in seven patients by in vivo labeling with diisopropy fluorophosphate, proved to be essentially normal. Thus, it appears that in chronic neutropenia, increased or decreased production of neutrophils is accomplished by increasing or decreasingZ early precursor input into the system.
INTRODUCTION
Using DF"P (diisopropyl fluorophosphate)' as a labeling compound, it is possible to measure the size of the total blood neutrophil pool (TBGP), the circulating neutrophil pool (CGP), and the marginal neutrophil pool (MGP) as well as the blood-neutrophil half disappearance time (ta) . From the ti and the TBGP, the neutrophil turnover rate (GTR) can be calculated. This is a measure of effective neutrophil production rate.
Such leukokinetic studies have defined normal neutrophil kinetics (1, 2) . The kinetics of neutrophilic granulocytes in a number of disease states with associated neutrophilia has also been characterized.
To assess the kinetic patterns of neutrophils in neutropenic states, 35 neutropenic patients were studied by means of the DF"2P-neutrophil kinetic method. In addition, a correlation between the kinetic results and a variety of clinical and laboratory findings was sought in the hope that an easy method of identifying the kinetic categories might be evolved. Some of these results have been reported previously (3) (4) (5) (6) .
METHODS
35 patients with neutrophil counts of 1830 cells/mm' or less were selected for study. However, because of fluctuation in neutrophil concentration in some of these patients, the blood neutrophil concentration was greater than 1830 cells/mm' on the day of study. Nevertheless, such patients were included as neutropenic patients, since they were clearly neutropenic during most of the observation period, both before and after the kinetic studies.
All subjects were in a steady state at the time of study. Only patients with neutrophil counts greater than 125/mm' could be studied.
'Abbreviations used in this paper: BGSA, blood neutrophil-specific activity; CGP, circulating neutrophil pool; DF'2P, diisopropyl fluorophosphate; GTR, neutophil turnover rate; MGP, marginal neutrophil pool; TBGP, total blood neutrophil pool.
After explanation of the proposed studies, all subjects consented to measurement of the size of the total-blood neutrophil pool (TBGP), circulating neutrophil pool (CGP), marginal neutrophil pool (MGP), half disappearance time (tj), and neutrophil turnover rate with the in vitro DF3P method (2) .'
Blood leukocyte concentration was measured by means of a Coulter Counter (Coulter Electronics) using a modification of the cetrimide-citrate lysing diluent (7) . At least 200 cells were counted on cover slip smears (Wright's stain) and absolute cell concentrations were calculated from this differential cell count and the blood leukocyte concentration. In our laboratory, the normal blood neutrophil concentration is 1,830-7,250/mm3, 95% limits (8) .
As in previous neutrophil kinetic studies (2) , the "determined" TBGP was calculated from the mean neutrophil radioactivity of two or three blood samples obtained 5-10 min after completion of the infusion. Also, as in previous studies, three types of blood neutrophil radioactivity curves were observed: (a) a single exponential blood neutrophilspecific activity (BGSA) curve, designated type "A" curves in the Tables; (b) an initial rapid fall in BGSA during the first 3 hr followed by a single exponential disappearance curve thereafter, designated type "B" curve in the Tables; and (c) a slurred curve (convexity downward) in which the tj was continually changing and could only be approximated as less than some maximal value, designated "C" curves in the Tables. The blood neutrophil-radioactivity   values were measured either as counts per minute per milligrams of neutrophil nitrogen, or as counts per minute per  107 neutrophils. A few patients were also studied by means of the in vivo DF32P-method in which DFP was injected intravenously (9, 10) . In these studies, the complex, triphasic curve was plotted on semilogarithmic graph paper and the best line depicting each phase was fitted to the data points by means of least squares. The duration of phase I + II was taken as a measure of the transit time through the marrow neutrophil reserve. The tj of phase III was taken as a measure of myelocyte generation time (3, 9, 10) .
Serum lysozyme levels were measured by the lyso-plate method described by Osserman and Lawlor (11) . Values are expressed as micrograms per milliliters and were read from a standard curve prepared from known dilutions of egg-white lysozyme (Difco Laboratories, Inc.).
Neutrophil mobilization capability was measured after cortisol or endotoxin injection as follows: after obtaining a control blood cell concentration, 200 mg of hydrocortisone phosphate3 was injected intravenously over a 5 min period.
Over the next 6 hr, hourly blood samples were obtained for measurement of leukocyte concentration and a differential cell count. The absolute neutrophil concentrations were plotted on arithmetic graph paper and the maximal change in neutrophil concentration (AN) expressed as the peak value minus the control, was recorded.
Endotoxin studies were identical to the cortisol studies except that 8 ,ug of Piromen' was injected intravenously to stimulate a neutrophil response. In addition, 0.50-1 ml of aspirated marrow was added to 1 ml of TC-199 culture medium (3) which contained 0.1 mg of dried heparin and 2.5 juCi of tritiated thymidine (thymidine-methyl 3H, 1.9 Ci/mM). This cell suspension was gently mixed every 10-15 min for 1 hr at 370C and then centrifuged at 280 g for 10 min at 40C. The supernatant was discarded and the cell button resuspended and washed in 1 ml of the patient's serum. After recentrifugation, the supernatant was again discarded, the cells were resuspended in several drops of serum and thin smears were prepared on cover slips. After fixation with methanol, the cover slips were mounted on glass slides and autoradiographs prepared using Kodak NTB-3 dipping film. The films were developed after a 24 hr exposure period and stained with Kingsley stain at pH 5.45 (12) . The proportion and type of myeloid cells labeled was determined for 500 myelocytes from each subject so studied.
Uric acid excretion per 24 hr was determined by the enzymatic method (13) .
RESULTS
Blood neutrophil production and turnover in chronic steady-state neutropenia
From a kinetic point of view, neutropenic patients can be categorized into those with a normal blood neutrophil ti value and those with a short tj value. In the present study, 17 patients fall into the normal ti category (Table I ) and 18 into the short ti category (Table II) . The patients in these categories can be further divided into groups on the basis of whether blood neutrophil production (GTR) was normal, decreased, or increased.
NEUTROPENIA CHARACTERIZED BY A NORMAL tj
The results obtained in the 17 patients with a normal ti are presented in Table I ; two patients with slightly long ti values are included in this category.
Effective neutrophil production was less than normal, as measured by the GTR, in 10 of these patients and this appears to explain their neutropenia (Table I-A). In two of these, marrow suppression by drugs was clearly documented (Cases 6 and 7) and in two others, untreated acute leukemia in relapse appeared to explain the decreased neutrophil production. In the remaining six patients, the cause of the neutropenia was not clear. In only 1 of these 10 patients was splenomegaly noted. Measurement of the TBGP in subject 3 resulted in a smaller value than the CGP, an impossible result. There would seem to be less error in measuring the CGP and Effective neutrophil production (GTR) was within the normal range in eight subjects with neutropenia and short ti values (Table II-B) . In five of these patients, the GTR was about twice the normal mean value; all five had spleno.iegaly. The neutropenia in this group of patients appears to have resulted mainly from the rapid turnover of a small or low-normal TBGP and a marrow that could increase production only moderately. The clinical diagnosis in this group of patients varied widely. Splenomegaly was noted in five of these eight patients.
Effective neutrophil production (GTR) was increased above the normal 95% limits in five neutropenic patients with short ti values (Table II-C). Of considerable interest are the findings that in all five patients: (a) TBGP was well within normal limits; (b) the CGP/TBGP ratio was less than 0.27 (a value rarely Fig. 1 -A that the serum lysozyme level in 20 normal subjects ranged from 30-65 /g/ml and that the lysozyme levels in the neutropenic patients were either normal or somewhat increased. There were three patients with elevated GTR in whom the serum lysozyme was measured. Of these, two were within normal limits and the third was only somewhat elevated. In addition, it is evident in Fig. 1 -B that even though the GTR ranged from 20 to 1100 X 10' N/kg/day (that is from 1/8 to 7 times the normal mean) there was no correlation between serum lysozyme levels and GTR in the 13 patients so studied. The lack of correlation existed whether the GTR was calculated from the TBGP or from the CGP.
Since lysozyme is only found in the urine of some patients with leukemia, no serious attempt to correlate GTR with urinary lysozyme was made. In the several neutropenic patients surveyed there was no lysozyme present in the urine. with short ti values (Fig. 2) . Nevertheless, no correlation between labeling index and GTR was demonstrable and no clear identification of a particular group of neutropenic patients (e.g. neutropenics with a short ti and increased GTR) was possible.
Short tj Values

MARROW NEUTROPHIL RESERVE IN NEUTROPHIL PATIENTS
To evaluate marrow neutrophil reserves in these neutropenic patients the change in blood neutrophil count after the injection of endotoxin or cortisol was studied. The results are included in Tables I and II and can be compared with results in normal subjects. In eight neutropenic patients in whom it was felt epinephrine infusion could be tolerated, a sudden transient increase in neutrophil concentration was obtained (rise and return to control levels in less than 15 min). The increase ranged from 60 to 2120 neutrophils/mm8 and tended to be large if the TBGP was large. However, there was no clear difference in the epinephrine response in patients who had a shift neutropenia and those with a true neutropenia.
The proportion of the TBGP present in the CGP/ TBGP ratio) in patients with "shift neutropenia" (TBGP > 27) and true neutropenia (TBGP < 27) can be compared with the distribution in normal subjects. In patients with "shift neutropeniall the CGP/TBGP ratio tended to be lower than in normal subjects and ranged from 0.06 to 0.46. In eight of these patients, the CGP/TBGP ratio was < 0.25, the lower limit of the normal range. The distribution of cells in the true neutropenic patients did not differ from that seen in normal subj ects.
It is of additional interest that although patients without detected splenomegaly may have short ti values, 12 of 14 patients with splenomegaly had short ti values (see Table II ). Also in the nine subjects with TBGP values greater than 40 (Fig. 3) , eight had short ti values and seven of these eight had splenomegaly. From this it can be argued that in such patients, rapid sequestration and removal of labeled cells from the blood during the 10-20 min needed to infuse them could have resulted in erroneously high TBGP values. However, if it is assumed that the ti measured in a subject also describes the rate of removal of cells during the infusion period, a correction can be made in the TBGP calculation for the error introduced by ignoring this removal.
(Ordinarily this error is very small (< 5%) when the ti is normal). Correction of the TBGP values in these eight patients did not bring the TBGP into the neutropenic range.
In vivo DF32P-kinetic studies
In an attempt to ascertain whether the pattern of neutrophil production in the marrow of neutropenic patients is different in decreased production neutropenia as compared with increased utilization and turnover states, several patients were given DF'P intravenously after the kinetic studies already described. In these in vivo-labeling studies, both blood and marrow neutrophilic cells are labeled and as the labeled blood cells leave the circulation (phase I in Fig. 4) placed by labeled cells from the marrow (phase II) (10). The time span over which the blood neutrophil radioactivity remains fairly stable is referred to as phase I plus II and gives a measure of the time required for myelocytes to mature in the marrow and enter the blood (9, 10). Though it has not gained wide acceptance, the ti of phase III is believed by us to reflect the generation time of the myelocyte compartment in the marrow (3, 9, 10) . It can be seen in Fig. 4 and Table III that the seven in vivo DF'P-kinetic studies carried out in neutropenic patients did not differ significantly from the results previously encountered in 21 normal volunteers. Even though one or two patients from each kinetic class were studied in this way, no difference in marrow to blood transit time (phase I + II) or in marrow myelocyte generation time (phase III ti) could be demonstrated.
Even in neutropenic patients with short ti time and increased blood GTR, the myelocyte to blood transit time and the myelocyte generation time were the same as in patients with purely decreased cell production (normal ti and low GTR).
DISCUSSION
From these studies it seems that neutropenia may be associated with decreased neutrophil production, an intravascular shift of cells, apparently to marginal sites, or rapid removal of neutrophils from the blood. Furthermore, in a patient with neutropenia, more than one of these pathogenic mechanisms may be operative at the same time.
The category of simple decreased-production neutropenia consists of patients with a low neutrophil turnover rate, a small blood neutrophil pool and normal ti values (Table I-A) . Several of these patients suffered from hematologic malignancies with marrow infiltration by abnormal cells; in several there was well-documented marrow suppression by drugs while in three or four the clinical diagnosis remains uncertain. In this group of patients neutropenia appears to be the result of a simple marrow production deficit.
Altered intravascular distribution of neutrophils appears to explain the neutropenia in a group of patients with low normal TBGP and GTR values and a normal tl (Table I-B) . The degree of cell redistribution as expressed by the CGP/TBGP ratio was less than the normal mean value of 0.46 in these patients but within the rather wide normal range (0.23-1.00) in all but two. The patients in this group suffered from a variety of clinical diseases but splenomegaly was an uncommon finding. It should be noted that the degree of neutropenia in these patients was mild in that all but one had neutrophil concentrations greater than 1,000/mm8. Also it should be noted that although epinephrine infusion will mobilize some marginated cells in neutropenic patients just as it does in normal subjects (2, 14) , it was not possible to differentiate altered distribution neutropenia from other neutropenic patients on the basis of this test.
The remainder of the patients studied appeared to have neutropenia of more complex pathogenesis. All exhibited an accelerated fractional turnover rate of the blood neutrophil pool; i.e., a short ti value, coupled with varying degrees of marrow production and altered cell distribution (Table II) . Two-thirds of these patients had splenomegaly.
Increased destruction seems to explain the neutropenia found in a group of patients with Felty's syndrome or hepatic cirrhosis (Table II-C) . These patients had short ti values, normal TBGP values, and elevated GTR values. In addition, a markedly altered intravascular cell distribution (CGP/TBGP ratio less than 0.27) was present in all. This presumably reflects sequestration in the spleen since splenomegaly was present in five of the six patients. As with the simple "shift" neutropenias mentioned above (Table I -B), the neutropenia was mild in that all subjects had neutrophil counts greater than 1,000 cells/mm'. This group of patients appear to be analogous to patients with wellcompensated hemolytic disease except that a shift of neutrophils out of the CGP into marginal sites makes them seem neutropenic even though the TBGP is normal. An alternative explanation for the findings in this group of patients is that the TBGP values are erroneously high. If this were the case, a normal TBGP coupled with a short ti would result in calculation of a high GTR when in fact the GTR may be normal or low. From the data collected this possibility cannot be excluded since there is no independent, alternative method for measuring TBGP and/or MGP size. However, if one calculates the GTR from the CGP rather than from the TBGP in these patients, the GTR values are still abnormal when compared to similarly calculated values for normal subjects. Such a calculation almost certainly underestimates the true GTR since no allowance for cells in the MGP is made.
The ti was shorter than normal in two other patient groups (Table II- A and B) . In spite of the fact that the TBGP was turning over rapidly in these subjects the blood neutrophil turnover rate was less than normal (Table II-A) or within the normal range (Table II-B) , apparently depending primarily on the size of the TBGP. Thus short neutrophil survival in the blood combined with inadequate marrow compensation appears to be the pathogenetic mechanism of the neutropenia in these patients. These two patient groups appear to be analogous to patients with hemolytic anemia who are unable to increase marrow production enough to compensate for accelerated blood cell removal. No patient with what might be called "ineffective granulocytopoiesis" was recognized in these studies. However, a cellular marrow biopsy coupled with a short ti and yet a low blood GTR in two patients (Table Il-A) suggests this possibility. Since no method for measuring marrow neutrophil production capability has yet been developed, ineffective granulocytopoiesis cannot be proven. The one patient with pernicious anemia studied had a normal GTR and a short ti (Table Il-B) .
Similar studies of blood neutrophil kinetics in small groups of patients with neutropenia, often associated with a particular disease such as hepatic cirrhosis (15, 16) , rheumatoid arthritis (17), or acute leukemia (18) , had been reported by other workers. There is general agreement concerning the kinetic classification groups just described except that the "shift neutropenia" group documented here (Table I-B) has not been reported previously. If the TBGP measurements in certain patients were artifactually high because of rapid removal of infused cells in some neutropenic patients it is clear that this would produce the picture of shift neutropenia. We do not think this is the case here because: (a) when the TBGP size is compared with the blood neutrophil concentration in all subjects studied, there is reasonable concordance between the two measurements in all but three subjects (Fig. 3) (23) in conjunction with blood neut studies might reveal a more clear relatior production capacity and blood GTR. Such been reported for the megakaryocyte-pI (24) and would be of great interest. In is worth noting that in no patient with a was a hypocellular marrow seen. However and unexplained finding is that even in ne tients with short ti values and apparent hypercellular marrows, the ability to re] neutrophils into the blood in response to ( or endotoxin was clearly less than norma did the increase in blood neutrophil cou stimulation reach normal values (Tables:
The essentially normal in vivo-kinetic curves ob-,TOMY tained in neutropenic patients (Fig. 4) have interesting implications in regard to the control of marrow neutrophil production. Possible mechanisms by which the marrow might attempt to compensate for neutropenia and increase cell output are: (a) an increased rate of differentiation and maturation of neutrophils with early release into the blood. Such an event should result in a short phase I + II (i.e. myelocyte to blood transit time). Sacchetti, Boccaccio, Ponassi, and Morra have reported short phase I + II values in patients made neutropenic by recent chemotherapy (25) "sink"; (e) combinations of these several mechanisms.
